الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> Fungal>>Tyrothricin

Tyrothricin

رقم الكتالوجGC18414

Tyrothricin هو مزيج مضاد حيوي متعدد البيبتيد معزول من Bacillus brevis ويتكون من tyrocidines و gramicidins

Products are for research use only. Not for human use. We do not sell to patients.

Tyrothricin التركيب الكيميائي

Cas No.: 1404-88-2

الحجم السعر المخزون الكميّة
1mg
44٫00
متوفر
5mg
121٫00
متوفر
10mg
171٫00
متوفر
25mg
269٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tyrothricin is a polypeptide antibiotic mixture produced by B. brevis.[1] [2]Tyrothricin is a mixture of tyrocidine and gramicidin that has rapid in vitro bactericidal activity against T. microdentium, T. macrodentium, T. vincentii, T. buccalis, T. mucosum, T. vaginalis, T. cruzi, and L. tropica. Preclinical studies demonstrate that intravenous use of tyrothricin leads to hemolysis-induced lethality (LD50s = 0.4 and 0.3 mg/kg, in dogs and mice, respectively) and damages liver, kidney, and olfactory tissues. Formulations containing tyrothricin are used topically to treat bacterial skin infections. [1][2]

Reference:
[1]. Dubos, R.J., and Hotchkiss, R.D. The production of bactericidal substances by aerobic sporulating bacilli. J. Exp. Med. 73(5), 629-640 (1941).
[2]. Lask, S.A. Tyrothricin as an antibiotic. Arch. Surg. 56(4), 475-483 (1948).

مراجعات

Review for Tyrothricin

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tyrothricin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.